Home › Funds › Tyro Capital Management LLC › EWTX

Tyro Capital Management LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Tyro Capital Management LLC reported holding 661,659 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 4.76% of its reported portfolio and ranking #9 among its reported holdings. Tyro Capital Management LLC has disclosed EWTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)661.66K sh
Reported value held$26.86M
Portfolio Weight4.76%
First reportedQ2 2026
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Tyro Capital Management LLC's EWTX position evolved

Tyro Capital Management LLC first disclosed a stake in EWTX in Q2 2026 at 612,965 shares (US$24.9M). The position peaked in Q3 2026 at 661,659 shares, worth US$26.9M. Across 2 filings, Tyro Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 661,659 shares valued at US$26.9M — an increase of 48,694 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 612.97K $24.90M New
Q3 2026 661.66K $26.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Tyro Capital Management LLC held EWTX?

Tyro Capital Management LLC has disclosed EWTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Tyro Capital Management LLC's current position in EWTX?

As of Q3 2026, Tyro Capital Management LLC holds 661.66K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $26.86M, representing 4.76% of its reported portfolio and ranking #9.

Has Tyro Capital Management LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Tyro Capital Management LLC increased its position in EWTX. The position peaked in Q3 2026 at 661.66K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.